Skip to main content
IDWeek 2023 Main banner
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Presentation Icons
Live Streamed
Live Streamed
On Demand
On Demand
Back

Session: New Antimicrobials in the Pipeline Part 1

31 - Xeruborbactam IV and Oral

Thursday, October 12, 2023
8:36 AM – 8:48 AM US ET
Location: 104 ABC
Disclosure(s):
Olga Lomovskaya, PhD: Qpex Biopharma, The Wholly Owned Subsidiary of Shionogy: I am the employee of Qpex Biopharma/Shionogi which is developing xerubprbactam (Ongoing)